HEADER HYDROLASE 29-JAN-03 1OBA TITLE MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 TITLE 2 COMPLEXED WITH CHOLINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MUREIN HYDROLASE, ENDOLYSIN, MURAMIDASE, CP-1 LYSIN; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTERIOPHAGE CP-1; SOURCE 3 ORGANISM_TAXID: 10747; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: DH1 (PCIP100) KEYWDS HYDROLASE, MUREIN HYDROLASE, CHOLINE, LYSOZYME, MULTIMODULAR, PHAGE KEYWDS 2 CP- 1 LYSIN, PNEUMOCOCCAL CELL WALL DEGRADATION, HYDROLASE KEYWDS 3 GLYCOSIDASE, BACTERILYTIC ENZYME EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HERMOSO,B.MONTERROSO,A.ALBERT,P.GARCIA,M.MENENDEZ,M.MARTINEZ- AUTHOR 2 RIPOLL,J.L.GARCIA REVDAT 3 13-DEC-23 1OBA 1 REMARK REVDAT 2 24-FEB-09 1OBA 1 VERSN REVDAT 1 17-OCT-03 1OBA 0 JRNL AUTH J.A.HERMOSO,B.MONTERROSO,A.ALBERT,B.GALAN,O.AHRAZEM, JRNL AUTH 2 P.GARCIA,M.MARTINEZ-RIPOLL,J.L.GARCIA,M.MENENDEZ JRNL TITL STRUCTURAL BASIS FOR SELECTIVE RECOGNITION OF PNEUMOCOCCAL JRNL TITL 2 CELL WALL BY MODULAR ENDOLYSIN FROM PHAGE CP-1. JRNL REF STRUCTURE V. 11 1239 2003 JRNL REFN ISSN 0969-2126 JRNL PMID 14527392 JRNL DOI 10.1016/J.STR.2003.09.005 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1622185.440 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 17479 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1202 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.60 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2352 REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE : 0.2980 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 179 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2741 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 257 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.22000 REMARK 3 B22 (A**2) : 2.32000 REMARK 3 B33 (A**2) : -2.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.670 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 42.10 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 192-197 WERE MODELED AS GLY REMARK 3 DUE TO POOR ELECTRON DENSITY DEFINITION. REMARK 4 REMARK 4 1OBA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-JAN-03. REMARK 100 THE DEPOSITION ID IS D_1290012041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17522 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1H09 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7M NA FORMATE, 0.1M NA CITRATE PH REMARK 280 6.0,1.8MM N-DECYL-MALTOSIDE, PH 6.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.65000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.65000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.97500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.97500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 64.65000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.97500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 64.65000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.01500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.97500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CARRIES OUT THE SEPARATION OF THE HOST DAUGHTER REMARK 400 CELLS AT THE END OF CELL DIVISION. ALSO PARTICIPATES IN THE REMARK 400 LIBERATION OF PROGENY BACTERIOPHAGE INTO THE MEDIUM.ACTIVITY REMARK 400 DEPENDS ON THE PRESENCE OF CHOLINE-CONTAINING CELL WALLS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 192 CB CG CD OE1 OE2 REMARK 470 ASP A 193 CB CG OD1 OD2 REMARK 470 ASP A 194 CB CG OD1 OD2 REMARK 470 LYS A 195 CB CG CD CE NZ REMARK 470 PRO A 196 CB CG CD REMARK 470 LYS A 197 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 38 -134.16 56.85 REMARK 500 SER A 126 -164.34 -178.31 REMARK 500 ASN A 179 -86.93 -31.10 REMARK 500 GLU A 192 60.08 -164.97 REMARK 500 ASP A 194 -117.28 138.12 REMARK 500 LYS A 195 51.20 27.26 REMARK 500 LYS A 197 163.55 52.94 REMARK 500 THR A 198 -163.49 -129.35 REMARK 500 SER A 206 -39.25 -38.00 REMARK 500 ASP A 234 172.81 -58.05 REMARK 500 ASP A 275 172.85 -58.22 REMARK 500 LYS A 288 -110.33 64.53 REMARK 500 THR A 318 -2.70 -50.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT A1340 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHT A1341 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H09 RELATED DB: PDB REMARK 900 MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONFLICT BETWEEN RESIDUE PRO AND ARG AT POSITION 44 REMARK 999 HAS BEEN DESCRIBED BY MARTIN ET AL., J.VIROL. 70,3678 REMARK 999 (1996). THE STANDARD RESIDUE AT POSITION 44 IS A PRO REMARK 999 IN THE SWISSPROT DATABASE ENTRY P15057. DBREF 1OBA A 1 339 UNP P15057 LYCA_BPCP1 1 339 SEQADV 1OBA ARG A 44 UNP P15057 PRO 44 CONFLICT SEQRES 1 A 339 MET VAL LYS LYS ASN ASP LEU PHE VAL ASP VAL SER SER SEQRES 2 A 339 HIS ASN GLY TYR ASP ILE THR GLY ILE LEU GLU GLN MET SEQRES 3 A 339 GLY THR THR ASN THR ILE ILE LYS ILE SER GLU SER THR SEQRES 4 A 339 THR TYR LEU ASN ARG CYS LEU SER ALA GLN VAL GLU GLN SEQRES 5 A 339 SER ASN PRO ILE GLY PHE TYR HIS PHE ALA ARG PHE GLY SEQRES 6 A 339 GLY ASP VAL ALA GLU ALA GLU ARG GLU ALA GLN PHE PHE SEQRES 7 A 339 LEU ASP ASN VAL PRO MET GLN VAL LYS TYR LEU VAL LEU SEQRES 8 A 339 ASP TYR GLU ASP ASP PRO SER GLY ASP ALA GLN ALA ASN SEQRES 9 A 339 THR ASN ALA CYS LEU ARG PHE MET GLN MET ILE ALA ASP SEQRES 10 A 339 ALA GLY TYR LYS PRO ILE TYR TYR SER TYR LYS PRO PHE SEQRES 11 A 339 THR HIS ASP ASN VAL ASP TYR GLN GLN ILE LEU ALA GLN SEQRES 12 A 339 PHE PRO ASN SER LEU TRP ILE ALA GLY TYR GLY LEU ASN SEQRES 13 A 339 ASP GLY THR ALA ASN PHE GLU TYR PHE PRO SER MET ASP SEQRES 14 A 339 GLY ILE ARG TRP TRP GLN TYR SER SER ASN PRO PHE ASP SEQRES 15 A 339 LYS ASN ILE VAL LEU LEU ASP ASP GLU GLU ASP ASP LYS SEQRES 16 A 339 PRO LYS THR ALA GLY THR TRP LYS GLN ASP SER LYS GLY SEQRES 17 A 339 TRP TRP PHE ARG ARG ASN ASN GLY SER PHE PRO TYR ASN SEQRES 18 A 339 LYS TRP GLU LYS ILE GLY GLY VAL TRP TYR TYR PHE ASP SEQRES 19 A 339 SER LYS GLY TYR CYS LEU THR SER GLU TRP LEU LYS ASP SEQRES 20 A 339 ASN GLU LYS TRP TYR TYR LEU LYS ASP ASN GLY ALA MET SEQRES 21 A 339 ALA THR GLY TRP VAL LEU VAL GLY SER GLU TRP TYR TYR SEQRES 22 A 339 MET ASP ASP SER GLY ALA MET VAL THR GLY TRP VAL LYS SEQRES 23 A 339 TYR LYS ASN ASN TRP TYR TYR MET THR ASN GLU ARG GLY SEQRES 24 A 339 ASN MET VAL SER ASN GLU PHE ILE LYS SER GLY LYS GLY SEQRES 25 A 339 TRP TYR PHE MET ASN THR ASN GLY GLU LEU ALA ASP ASN SEQRES 26 A 339 PRO SER PHE THR LYS GLU PRO ASP GLY LEU ILE THR VAL SEQRES 27 A 339 ALA HET CHT A1340 7 HET CHT A1341 7 HETNAM CHT CHOLINE ION FORMUL 2 CHT 2(C5 H14 N O 1+) FORMUL 4 HOH *257(H2 O) HELIX 1 1 SER A 12 GLY A 16 5 5 HELIX 2 2 ILE A 19 GLY A 27 1 9 HELIX 3 3 CYS A 45 GLN A 52 1 8 HELIX 4 4 ASP A 67 ASP A 80 1 14 HELIX 5 5 ASP A 100 ALA A 118 1 19 HELIX 6 6 LYS A 128 VAL A 135 1 8 HELIX 7 7 ASP A 136 ALA A 142 1 7 HELIX 8 8 ASN A 161 PHE A 165 5 5 HELIX 9 9 ASN A 296 ASN A 300 5 5 SHEET 1 AA11 LEU A 7 VAL A 11 0 SHEET 2 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 3 AA11 ILE A 171 SER A 177 -1 O TRP A 174 N ILE A 185 SHEET 4 AA11 LEU A 148 ALA A 151 1 O LEU A 148 N ARG A 172 SHEET 5 AA11 LYS A 121 TYR A 127 1 O TYR A 124 N TRP A 149 SHEET 6 AA11 TYR A 88 ASP A 92 1 O LEU A 89 N ILE A 123 SHEET 7 AA11 ASN A 54 PHE A 61 1 O ILE A 56 N TYR A 88 SHEET 8 AA11 ASN A 30 GLU A 37 1 O THR A 31 N ILE A 56 SHEET 9 AA11 LEU A 7 VAL A 11 1 O VAL A 9 N ILE A 32 SHEET 10 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 11 AA11 LEU A 7 VAL A 11 -1 O PHE A 8 N ASN A 184 SHEET 1 AB 2 GLY A 200 ASP A 205 0 SHEET 2 AB 2 GLY A 208 ARG A 213 -1 O GLY A 208 N ASP A 205 SHEET 1 AC 2 LYS A 222 ILE A 226 0 SHEET 2 AC 2 VAL A 229 PHE A 233 -1 O VAL A 229 N ILE A 226 SHEET 1 AD 2 GLU A 243 ASP A 247 0 SHEET 2 AD 2 LYS A 250 LEU A 254 -1 O LYS A 250 N ASP A 247 SHEET 1 AE 2 GLY A 263 VAL A 267 0 SHEET 2 AE 2 GLU A 270 MET A 274 -1 O GLU A 270 N VAL A 267 SHEET 1 AF 6 GLU A 321 LEU A 322 0 SHEET 2 AF 6 GLY A 312 ASN A 317 -1 N ASN A 317 O GLU A 321 SHEET 3 AF 6 VAL A 302 SER A 309 -1 O GLU A 305 N MET A 316 SHEET 4 AF 6 ASN A 290 THR A 295 -1 O TRP A 291 N PHE A 306 SHEET 5 AF 6 GLY A 283 TYR A 287 -1 O GLY A 283 N MET A 294 SHEET 6 AF 6 LEU A 335 THR A 337 1 O LEU A 335 N LYS A 286 SITE 1 AC1 4 TRP A 223 TRP A 230 TYR A 252 SER A 277 SITE 1 AC2 5 TRP A 202 TRP A 209 TYR A 231 ASN A 257 SITE 2 AC2 5 HOH A2257 CRYST1 78.030 95.950 129.300 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012815 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010422 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007734 0.00000